Table 2.
Participant characteristics.
| Overall | NEDA-3 positive | NEDA-3 negative | |
|---|---|---|---|
| Participants—number (%) | 186 | 87 (47) | 99 (53) |
| Sex—number (%) | |||
| Male | 35 | 15 (17) | 20 (20) |
| Female | 151 | 72 (83) | 79 (80) |
| Age | |||
| Mean (±SD) | 48 (±13.0) | 51 (±12.7) | 46 (±13.0) |
| Range | 21–76 | 22–73 | 21–76 |
| Type of MS—number (%) | |||
| Relapsing remitting | 159 | 73 (84) | 86 (87) |
| Secondary progressive | 23 | 13 (15) | 10 (10) |
| Primary progressive | 3 | 1 (1) | 2 (2) |
| Progressive relapsing | 1 | 0 (0) | 1 (1) |
| Time since symptom onset of MS—years | |||
| Mean (±SD) | 15 (±10.2) | 17 (±10.9) | 14 (±9.4) |
| Range | 3–56 | 3–56 | 2–42 |
| Treatment—number (%) | |||
| No treatment | 21 | 8 (9) | 13 (13) |
| Injectable | 19 | 16 (18) | 3 (3) |
| Oral | 74 | 34 (39) | 40 (40) |
| Monoclonal | 72 | 29 (33) | 43 (43) |
| Participants on diets—number (%) | |||
| MS specific diet | 20 | 8 (9) | 12 (12) |
| Dairy-free diet | 13 | 4 (5) | 9 (9) |
| Gluten-free diet | 8 | 4 (5) | 4 (4) |
| Both dairy- and gluten-free diet | 2 | 1 (1) | 1 (1) |
Percentages to the nearest whole. Standard deviations to the nearest decimal place. NEDA-3: no evidence of disease activity 3; MS: multiple sclerosis.